Johnson Investment Counsel’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
74,651
-551
-0.7% -$12.8K 0.01% 382
2026
Q1
$2.02M Sell
75,202
-17,390
-19% -$565K 0.02% 322
2025
Q4
$2.95M Sell
92,592
-18,400
-17% -$540K 0.02% 240
2025
Q3
$3.08M Buy
110,992
+22,536
+25% +$653K 0.03% 230
2025
Q2
$2.87M Buy
88,456
+765
+0.9% +$24.7K 0.03% 232
2025
Q1
$3.06M Buy
87,691
+3,120
+4% +$97.9K 0.03% 217
2024
Q4
$1.96M Sell
84,571
-5,430
-6% -$137K 0.02% 292
2024
Q3
$2.82M Buy
90,001
+13,370
+17% +$410K 0.03% 233
2024
Q2
$2.12M Hold
76,631
0.02% 263
2024
Q1
$2.57M Buy
76,631
+14,280
+23% +$462K 0.03% 228
2023
Q4
$2.1M Hold
62,351
0.02% 248
2023
Q3
$2.02M Buy
62,351
+11,480
+23% +$387K 0.03% 242
2023
Q2
$1.65M Buy
+50,871
New +$1.53M 0.02% 275

Other funds holding OPCH

Johnson Investment Counsel's OPCH Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Option Care Health (OPCH) stake by 0.73% in Q2 2026, selling an estimated $12.8K and leaving 74,651 shares worth $1.57M. The position accounts for 0.01% of the portfolio, ranked #382.

Johnson Investment Counsel first reported a position in OPCH in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.08M in Q3 2025. 370 funds tracked by Wall St. Rank hold OPCH as of Q2 2026.

  • Johnson Investment Counsel held 74,651 shares of Option Care Health worth $1.57M as of Q2 2026.
  • Johnson Investment Counsel sold 551 Option Care Health shares in Q2 2026, an estimated $12.8K.
  • Option Care Health made up 0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #382 holding.
  • Johnson Investment Counsel first reported a position in Option Care Health in Q2 2023 and has held it in 13 quarters since.
  • Johnson Investment Counsel's Option Care Health position peaked at $3.08M in Q3 2025.
  • 370 funds tracked by Wall St. Rank held Option Care Health as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.